DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma
Discover Oncology · 08.03.2026 · 17 (1)
DOI: 10.1007/s12672-026-04743-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 08.03.2026. Verfasst von Hongxing Ye und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China. zypeng@csu.edu.cn.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China. zypeng@csu.edu.cn.
- Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. 1320110@zju.edu.cn.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Ye, H., Zhang, C., Bu, L., Xiao, F., Weng, Y., Huang, K., Fang, Z., Fan, W., Jiang, H., Zhu, Y., Zhan, R., Zheng, X., Wang, Y., Peng, Z., & Zhang, L. (2026). DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04743-5
Vancouver
Ye H, Zhang C, Bu L, Xiao F, Weng Y, Huang K, et al. DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04743-5
BibTeX
@article{Ye2026,
author = {Ye, Hongxing and Zhang, Chao and Bu, Linghao and Xiao, Feng and Weng, Yuxiang and Huang, Kaiyuan and Fang, Zebin and Fan, Weijian and Jiang, Hao and Zhu, Yu and Zhan, Renya and Zheng, Xiujue and Wang, Yumin and Peng, Zhouying and Zhang, Luyuan},
title = {DENND2D serves as a novel prognostic biomarker with paradoxical protumorigenic effects in glioma},
journal = {Discover Oncology},
year = {2026},
volume = {17},
number = {1},
doi = {10.1007/s12672-026-04743-5}
}
EUVIMED